Advances and challenges in developing expandable human hepatocytes for regenerative medicine

Area of Science:

• Hepatology
• Regenerative Medicine
• Cell Therapy

Background:

• Liver transplantation is the only cure for severe liver disease, but donor scarcity necessitates alternative treatments.
• Hepatocyte transplantation is a potential alternative, yet limitations in expandable cell sources hinder its progress.
• Current research focuses on developing culture systems to maintain hepatocyte proliferative and functional capacities.

Purpose of the Study:

• To review the historical context of hepatocyte transplantation.
• To summarize advancements in expandable hepatocyte technologies.
• To discuss the challenges impeding clinical translation of hepatocyte transplantation.

Main Methods:

• Review of historical data and recent scientific literature on hepatocyte expansion and transplantation.
• Analysis of progress in organoid technologies for liver regeneration.
• Evaluation of factors influencing cell engraftment and repopulation efficiency.

Main Results:

• Recent progress in expandable hepatocytes and organoid technologies has shown partial success in repopulating injured mouse livers.
• Despite advances, achieving sufficient cell numbers and robust repopulation efficiency remains a significant hurdle.
• Engraftment success and replacement efficiency are critical determinants of repopulation extent.

Conclusions:

• Hepatocyte transplantation holds promise but requires overcoming challenges in cell expansion and engraftment for clinical application.
• Further research into scalable hepatocyte culture and transplantation optimization is crucial.
• Addressing these challenges is key to realizing the therapeutic potential of hepatocyte transplantation.